Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects [Phase 1]

View source ↗

Summary

The trial evaluates safety, tolerability, and pharmacokinetics of an orally inhaled DNAzyme solution delivered by nebulization in healthy male volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DNAzyme inhalation solution (DNAzyme inhalation solution)

Snippet

Sponsor: Sterna Biologicals GmbH & Co. KG | Conditions: Asthma | Phase 1 | Status: COMPLETED